127 related articles for article (PubMed ID: 21530311)
1. MR-guided radiofrequency ablation of hepatocellular carcinoma: long-term effectiveness.
Clasen S; Rempp H; Boss A; Schmidt D; Fritz J; Schraml C; Schick F; Claussen CD; Pereira PL
J Vasc Interv Radiol; 2011 Jun; 22(6):762-70. PubMed ID: 21530311
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
[TBL] [Abstract][Full Text] [Related]
3. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index.
Kao WY; Chiou YY; Hung HH; Chou YH; Su CW; Wu JC; Huo TI; Huang YH; Lin HC; Lee SD
Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):528-36. PubMed ID: 21537128
[TBL] [Abstract][Full Text] [Related]
5. Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model.
Ikeda K; Kobayashi M; Kawamura Y; Imai N; Seko Y; Hirakawa M; Hosaka T; Sezaki H; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Liver Int; 2011 May; 31(5):692-9. PubMed ID: 21457441
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
7. Transhepatic CT-guided radiofrequency ablation of adrenal metastases from hepatocellular carcinoma.
Kuehl H; Stattaus J; Forsting M; Antoch G
Cardiovasc Intervent Radiol; 2008; 31(6):1210-4. PubMed ID: 18584241
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation of liver cancer.
Lencioni R; Crocetti L
Tech Vasc Interv Radiol; 2007 Mar; 10(1):38-46. PubMed ID: 17980317
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
Kim YS; Rhim H; Cho OK; Koh BH; Kim Y
Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240
[TBL] [Abstract][Full Text] [Related]
10. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors and prognosis for patients with residual tumor after radiofrequency ablation of hepatocellular carcinoma].
Yang LT; Wang XB; Zhang YL; Huang L; Xu ZY; Cheng XD; Guo JM
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):309-12. PubMed ID: 20510087
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
[TBL] [Abstract][Full Text] [Related]
13. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI
Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
[TBL] [Abstract][Full Text] [Related]
14. Recent advances of radiofrequency ablation for early hepatocellular carcinoma.
Izumi N
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():115-22. PubMed ID: 21199522
[TBL] [Abstract][Full Text] [Related]
15. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
16. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients.
Li WH; Ma KW; Cheng M; Chui KH; Chan PT; Chu WH; Fung HS; Kowk CH; Cheung MT
ANZ J Surg; 2010 Oct; 80(10):714-21. PubMed ID: 21040332
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of needle tract seeding in hepatocellular carcinoma.
Espinoza S; Briggs P; Duret JS; Lapeyre M; de Baère T
J Vasc Interv Radiol; 2005 May; 16(5):743-6. PubMed ID: 15872331
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
[TBL] [Abstract][Full Text] [Related]
20. Factors in successful radiofrequency ablation therapy for malignant liver tumors.
Sakakima Y; Inoue S; Takeda S; Kaneko T; Nakao A
Hepatogastroenterology; 2004; 51(60):1761-5. PubMed ID: 15532821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
